Assets under management of mutual funds investing in global markets have shrunk over the past 20 months. Even the long-term category average returns pale in comparison to some in the debt funds bucket. What is ailing global funds and are they still a good portfolio diversification tool. Moneycontrol spoke to Chintan Haria, head products strategy at ICICI Prudential Mutual Fund for answers.

Read More

​ Assets under management of mutual funds investing in global markets have shrunk over the past 20 months. Even the long-term category average returns pale in comparison to some in the debt funds bucket. What is ailing global funds and are they still a good portfolio diversification tool. Moneycontrol spoke to Chintan Haria, head products strategy at ICICI Prudential Mutual Fund for answers. Assets under management of mutual funds investing in global markets have shrunk over the past 20 months. Even the long-term category average returns pale in comparison to some in the debt funds bucket. What is ailing global funds and are they still a good portfolio diversification tool. Moneycontrol spoke to Chintan Haria, head products strategy at ICICI Prudential Mutual Fund for answers.  Moneycontrol Latest News Read More  

Assets under management of mutual funds investing in global markets have shrunk over the past 20 months. Even the long-term category average returns pale in comparison to some in the debt funds bucket. What is ailing global funds and are they still a good portfolio diversification tool. Moneycontrol spoke to Chintan Haria, head products strategy at ICICI Prudential Mutual Fund for answers.

Motilal Oswal recommended Neutral rating on Zensar with a target price of Rs 520 in its research report dated October 17, 2023.

Read More

​ Motilal Oswal recommended Neutral rating on Zensar with a target price of Rs 520 in its research report dated October 17, 2023. Motilal Oswal recommended Neutral rating on Zensar with a target price of Rs 520 in its research report dated October 17, 2023.  Moneycontrol Latest News Read More  

Motilal Oswal recommended Neutral rating on Zensar with a target price of Rs 520 in its research report dated October 17, 2023.

A graphical snapshot of the service sector-led economy of the election-bound state, which has struggled to meet its fiscal deficit targets.

Read More

​ A graphical snapshot of the service sector-led economy of the election-bound state, which has struggled to meet its fiscal deficit targets. A graphical snapshot of the service sector-led economy of the election-bound state, which has struggled to meet its fiscal deficit targets.  Moneycontrol Latest News Read More  

A graphical snapshot of the service sector-led economy of the election-bound state, which has struggled to meet its fiscal deficit targets.

A graphical snapshot of the service sector-led economy of the election-bound state, which has struggled to meet its fiscal deficit targets.

Read More

​ A graphical snapshot of the service sector-led economy of the election-bound state, which has struggled to meet its fiscal deficit targets. A graphical snapshot of the service sector-led economy of the election-bound state, which has struggled to meet its fiscal deficit targets.  Moneycontrol Latest News Read More  

A graphical snapshot of the service sector-led economy of the election-bound state, which has struggled to meet its fiscal deficit targets.

Biggest losers included Bajaj Finance, Bajaj Finserv, NTPC, HDFC Bank and Axis Bank, while gainers were Cipla, Dr Reddy#39;s Laboratories, Tata Motors, Sun Pharma and SBI Life Insurance

Read More

​ Biggest losers included Bajaj Finance, Bajaj Finserv, NTPC, HDFC Bank and Axis Bank, while gainers were Cipla, Dr Reddy#39;s Laboratories, Tata Motors, Sun Pharma and SBI Life Insurance Biggest losers included Bajaj Finance, Bajaj Finserv, NTPC, HDFC Bank and Axis Bank, while gainers were Cipla, Dr Reddy#39;s Laboratories, Tata Motors, Sun Pharma and SBI Life Insurance  Moneycontrol Latest News Read More  

Biggest losers included Bajaj Finance, Bajaj Finserv, NTPC, HDFC Bank and Axis Bank, while gainers were Cipla, Dr Reddy#39;s Laboratories, Tata Motors, Sun Pharma and SBI Life Insurance

The decision, which will cost a total of Rs 12,857 crore per year, will benefit 48.67 lakh central government employees and 67.95 lakh pensioners

Read More

​ The decision, which will cost a total of Rs 12,857 crore per year, will benefit 48.67 lakh central government employees and 67.95 lakh pensioners The decision, which will cost a total of Rs 12,857 crore per year, will benefit 48.67 lakh central government employees and 67.95 lakh pensioners  Moneycontrol Latest News Read More  

The decision, which will cost a total of Rs 12,857 crore per year, will benefit 48.67 lakh central government employees and 67.95 lakh pensioners

IndusInd Bank Q2 earnings: The net profit came higher than the market estimates of Rs 2,128 crore

Read More

​ IndusInd Bank Q2 earnings: The net profit came higher than the market estimates of Rs 2,128 crore IndusInd Bank Q2 earnings: The net profit came higher than the market estimates of Rs 2,128 crore  Moneycontrol Latest News Read More  

IndusInd Bank Q2 earnings: The net profit came higher than the market estimates of Rs 2,128 crore

Rajgor Castor Derivatives IPO | The company that manufactures castor oil-based productsrnintends to mop up Rs 47.81 crore via a public issue of 95.61 lakh equity shares at the upper price band.

Read More

​ Rajgor Castor Derivatives IPO | The company that manufactures castor oil-based productsrnintends to mop up Rs 47.81 crore via a public issue of 95.61 lakh equity shares at the upper price band. Rajgor Castor Derivatives IPO | The company that manufactures castor oil-based productsrnintends to mop up Rs 47.81 crore via a public issue of 95.61 lakh equity shares at the upper price band.  Moneycontrol Latest News Read More  

Rajgor Castor Derivatives IPO | The company that manufactures castor oil-based productsrnintends to mop up Rs 47.81 crore via a public issue of 95.61 lakh equity shares at the upper price band.

About 1,424 shares advanced, 2,144 shares declined and 1.37 shares remained unchanged

Read More

​ About 1,424 shares advanced, 2,144 shares declined and 1.37 shares remained unchanged About 1,424 shares advanced, 2,144 shares declined and 1.37 shares remained unchanged  Moneycontrol Latest News Read More  

About 1,424 shares advanced, 2,144 shares declined and 1.37 shares remained unchanged

Motilal Oswal is bullish on Bajaj Finance recommended buy rating on the stock with a target price of Rs 9600 in its research report dated October 18, 2023.

Read More

​ Motilal Oswal is bullish on Bajaj Finance recommended buy rating on the stock with a target price of Rs 9600 in its research report dated October 18, 2023. Motilal Oswal is bullish on Bajaj Finance recommended buy rating on the stock with a target price of Rs 9600 in its research report dated October 18, 2023.  Moneycontrol Latest News Read More  

Motilal Oswal is bullish on Bajaj Finance recommended buy rating on the stock with a target price of Rs 9600 in its research report dated October 18, 2023.